Research Article :
Despoina G Alamanou, Konstantinos Giakoumidakis, Dimosthenis G Theodosiadis, Nikolaos V Fotos, Elissavet Patiraki and Hero Brokalaki Objective: In Greece, the old phenomenon of hiding cancer diagnosis and depriving cancer patients of their right to participate in decision-making remains a reality. The aim of this study was to assess the decision-making preferences of Greek cancer patients and their awareness of diagnosis. Methods: It was a cross-sectional study. The sample consisted of 229 adult Greek patients diagnosed with cancer, attending the oncology outpatient department (outpatients) or being hospitalized (inpatients), in one general hospital in Athens. Patients who were aware of cancer diagnosis (n=209) were administered at the Control Preference Scale (CPS), a tool, designed to elicit decision-making preferences. The IBM SPSS program, version 21.0 was used for statistical analysis. Results: One hundred and one patients (52.8%) were males. The mean [±standard deviation (SD)] age was 64.8 (±11.2) years. The vast majority of patients knew they suffered from cancer (n=209, 91.3%). Older patients (p=0.003), those who lived in suburbs of the city (p=0.01), those who had lower educational level (p=0.001), those with lower personal income (p=0.001) and shorter disease duration (p=0.001) stated that were unaware of cancer diagnosis. Seventy five (36.2%) patients chose the shared-decision role in decision-making procedures. Lower age (OR 1.04, 95%, CI: 1.00-1.08, p= 0.05) and higher education level (OR 2, 63, 95%, CI: 1.11-6.29, p=0.03) were significantly associated with the preference of patients to actively participate in decision-making regarding treatment. Conclusions: Although Greek cancer patients are aware of cancer diagnosis and treatment, nowadays, they still seem to hesitate in playing a more active role in the decision-making procedures, which portrays the impact of the dominating paternalistic model of doctor-patient relationship in the Greek medical encounter. Human
deaths due to cancer have risen sharply, in recent years. Cancer
is one of the most important causes of morbidity and mortality, worldwide, with
nearly 14 million new cases in 2012 [1]. It, also, remains the second leading
cause of death in the world and is responsible for 8.8 million deaths in 2015 [2].
In Greece, cancer is the second leading cause of death and accounts for about
25,000 deaths a year, according to the latest measurements [3]. Diagnosis
of cancer is likely to cause uncertainty and anxiety to patients, emotions that
can be eliminated by providing timely and valid information regarding
diagnosis, prognosis and treatment options. Patients’
awareness of cancer diagnosis and integrated communication with healthcare
professionals are found to be essential for the effective management of the
disease, as well as, the reduction of emotional transitions, improved patients’
quality of life and communication with family members [4-8]. Although, studies
from different countries support the fact that the majority of patients with
cancer need to be well informed about diagnosis and cancer treatment and more
active in the decision-making process, there are still many cancer patients
unaware of their true diagnosis, worldwide, an attitude that is considered
acceptable in many societies [9-14]. Particular emphasis has also been given in
recent decades on patients’ autonomy and their involvement in decisions
regarding treatment [15-16]. Patients’
roles in treatment decision making can differ from playing a passive role,
where all decision are made by the physician, through sharing role, to an
active role, in which patients decide themselves about treatment. In the United
States, National health organizations Recommend the inclusion of patients in
decision-making procedures [8,17]. However, researches support that patient’s
wish to more information and participation in decision making is personalized,
may change through time and can be influenced by social, economic and cultural
factors, while other studies result that patients wishes are often
underestimated by healthcare professional for various reasons [2,5,16,18-21]. The
latest international literature review shows that cancer
patients are more active than ever in the decision-making process. Specifically,
75% of cancer patients with hematological malignancies chose the shared
decision-making according to a recent study in Netherlands. Also, in a study in
USA the majority (53%) of the 119 Hispanic American patients preferred shared
decision-making with their doctor, while only 7,6% had a passive
decision-making style [22,23]. In
Greece, paternalism
is not challenged yet and the consumerist model of health care is not strongly
developed [6]. In recent years, choices of cancer treatment are discussed with
some patients, depending on factors such as educational level, age and health
status, however, Greek physicians often decide on their own the most
appropriate treatment, without having informed the patient first about the
disease and the available treatment options. In 2005, Greek general
practitioners reported that heavy workloads and lack of time are responsible
for incomplete information and promotion of counseling to cancer patients [24]. Consequently,
the aim of this study was to evaluate Greek cancer patients’ awareness of
diagnosis, nowadays, and assess their decision-making preferences regarding
treatment. Very few studies have been conducted in Greece regarding awareness
of cancer diagnosis, with the majority of them being conducted in the previous
decade and only two studies have been carried out regarding decision-making
preferences among Greek cancer patients [6,16,25-27]. Study
Design and Participants It
was a cross-sectional study, conducted in a large general public hospital of Athens.
316 cancer patients were collectively treated in the pathology
clinics and the outpatient department of the study hospital, from January 2013
to August 2014. The inclusion criteria used were The
exclusion criteria used were The
first five exclusion criteria were used because their existence could affect
patients’ consciousness and perception during the interview but also their
answers regarding their preferences on their role in treatment decisions of the
316 patients, 21 had an individual history of psychiatric
disease, 46 patients had Alzheimer's disease or a form of dementia and 13
patients had a co-existing life-threatening disease (5 patients had end-stage
heart failure and 8 patients had chronic renal failure under hemodialysis). According
to the inclusion criteria, 236 patients could have been admitted to the study.
Out of those patients, 229 agreed to participate in the study (response rate
97.03%). The sixth exclusion criterion was used subsequently for the admission
at the Control Preference Scale tool. The final sample of patients that
completed the CPS-Greek edition questionnaire was 209. Collection
of Data and Measures Demographic
data, diagnosis and clinical characteristics were obtained by patients’ medical
records review. Adequate data were collected by means of semi structured
interviews. The Control Preference Scale (CPS) instrument was used in this
study for the assessment of patients’ decision-making preferences. Patients
were evaluated as to whether they had knowledge of their diagnosis and what
this was through interview. Those who knew their diagnosis was cancer (n=209)
were administered to the CPS tool. The
CPS created by Degner et al. [28] is an assessment tool which measures the
decision-making preferences of cancer patients [29]. It is a clinically
relevant, easy-to-administer, reliable and valid measure of roles (preferred
and actual) in decision making on health care issues among cancer patients [30].
It consists of five cards (A to E), each describing a potential role of the
patient in relation to the physician, whenever a decision about treatment is
made. Every card has a statement that describes the role and is illustrated by
a cartoon in order to assist patients of lower literacy level to understand the
meaning. The roles range from (A) the patient being the primary decision maker,
(C) shared decision making, to (E) patient being completely passive to the
physician’s decisions. In
this study, the cards were presented to each patient who was asked to choose
the one that was closer to his/her preferences in a hypothetical scenario of a
consultation with their oncologist, when a decision about treatment must be
made. In this way, patients felt free to choose the role they really prefer to
play in the decision making process, without worrying about their physician’s
opinion. The CPS was translated from English to Greek by Almyroudi et al. [16].
Ethical approval was obtained from the research team that conducted the Greek
translation for the use of the CPS-Greek edition questionnaire. Ethics A
written authorization was obtained from the Ethics Committee and the Scientific
Council of the hospital that was chosen for the study. Patients were invited to
participate in the study and were then provided with additional information
about the research. Prior to the interview, patients who were recruited read
and signed information consent form. The research was conducted with respect to
the patients and the confidentiality of the collected data in accordance with
the Helsinki Declaration of 1975, as revised in 2013. Statistical
Analysis Continuous
variables are presented with mean and Standard Deviation (SD) or with median
and Interquartile Range (IQR). Qualitative variables are presented with
absolute and relative frequencies. The Kolmogorov-Smirnov test and graphs
(histograms and normal Q-Q plots) were used to test the normality of the
distribution of the continuous variables. Demographic and clinical
characteristics were independent variables while the role patients prefer
to play in the decision-making process was the dependent dichotomous variable. Bivariate
analyses between demographic and clinical characteristics and the role patients
prefer to play in the decision-making process included chi-square test,
chi-square trend test, independent samples
t-test and Mann-Whitney test. We used chi-square test in case of categorical
demographic and clinical characteristics and chi-square trend test in case of
ordinal variables. Also, we used independent samples t-test in case of
continuous variables that followed normal distribution and Mann-Whitney test in
case of continuous variables that did not follow normal distribution.
Demographic and clinical characteristics with p<0.20 in bivariate analyses,
were entered into the backward stepwise multivariate logistic regression analysis
with the role patients prefer to play in the decision-making process as the
dependent variable. Multivariate
analysis was used to control potential confounding variables. Criteria for
entry and removal of variables were based on the likelihood ratio test, with
enter and remove limits set at p<0.05 and p>0.05. We estimated adjusted
odds ratios with 95% confidence intervals for the predictive factors related to
the role patients prefer to play in the decision-making process. All tests of
statistical significance were two-tailed, and P values of less than 0.05 were
considered significant. The Statistical Package for Social Sciences (IBM SPSS) program,
version 21.0. (IBM Corp. Released 2012. IBM SPSS Statistics for Windows, version
21.0. Armonk, NY: IBM Corp.) was used for statistical analysis. Sample
Description There
were no complaints regarding the time of the completion and understanding of
the questionnaire. Participants were mostly male (n=121), with an average age
64.8 years (SD=11.2). Most of the patients (n=102) were high/secondary school
graduates and 46.7% of them (n=107) had a monthly personal income of 600-1.000€.
Nearly one fifth of the patients (19.2%) were diagnosed with breast cancer and
18.8% (n=43) with lung
cancer. The median duration of their Diagnose was 22.5 months (IQR: 1-128,
SD: 28.3). Almost half patients (n=106) had no metastatic cancer, while 28.8%
(n=66) of patients had undergone chemotherapy. Most of the participants were
under therapeutical
treatment (n=136), while 40.6% were under supportive treatment. Patients'
demographic and clinical characteristics are presented in Table 1 and 2. Awareness
of Diagnosis As
shown in Table 1, the vast majority (91.3%) of study patients were aware of
their diagnosis being cancer. However, 20 patients reported that they did not
know their diagnosis. The mean age of patients who knew they suffer from cancer
was statistically significant lower than those who did not know (64.1 years
versus 71.9, p=0.003). Patients living in an urban area were significantly more
likely to know their diagnosis, compared to patients living in a semi-rural and
rural area (p=0.01). Higher educational level was statistical significantly
related to the patients’ knowledge of cancer diagnosis (p<0.001). Increased
monthly personal income was also statistically significant related to patient
awareness of diagnosis (p= 0.001). The
median duration of the disease of patients, who were aware of cancer diagnosis
was statistically significantly higher than those who stated that they did not
know their diagnosis was cancer (12 months versus 5, p=0.001). Patients with
continuation/change of treatment were more likely to know they had cancer than
those in the first cycle of treatment
(p<0.001). Patients with no co-existing disease were significantly more
likely to know they have cancer than those with a co-existing disease (p=0.03).
In addition, all outpatients knew their diagnosis, while 14.4% of inpatients
claimed they did know their diagnosis was cancer (p<0.001). Due to the
variety of cancer diagnosis and the number of patients, Table 2 shows the most
frequent cancer types of the study patients and the majority of the treatment
combination they underwent. Table2:Patients’ clinical characteristics Patients’
Decision-Making Preferences As
shown in Table 3, 36.2% (n=75) of
patients chose to play a shared-decision role with their doctor in the decision-making
process. 33.3% (n=69) preferred their doctor to make the final decision
regarding treatment after taking the patient’s opinion seriously (passive
collaboration role), while only 0.5% (n=1) of patients chose to make all
decisions regarding treatment on their own (active role). Bivariate analysis revealed the relationship
between demographic and clinical characteristics of the study patients and
their preferred role in the decision making process. Patients who chose the
passive and passive/collaborative role constituted one category (passive role)
(n=121), while patients who chose shared-decision, active/ collaborative and
active role constituted the second category (non-passive role) (n=88).
Dependent variable was the role patients prefer to play in the decision making
process. Table 4 shortly represents the most important results of the
analysis. Table 3: Patients’ decision-making preferences After the bivariate
analysis, there was a statistically significant relationship (p<0.20)
between the role patients prefer to play in the decision-making process and the
age, residence, education, the existence of children, the occupational status,
the monthly personal income, the existence of metastases, the type of treatment
and the type of patients (outpatients/inpatients). For this reason, multivariate
regression analysis was conducted, with a dependent variable the role
patients prefer to play in the decision-making process (non-passive role:
reference category), the results of which are presented in Table 5. The results of the multivariate regression analysis showed that older patients and those with lower educational level had an almost 1.04 and 2.63 times greater probability to adopt a passive role in decision-making procedures. The above variables interpret the 37% of the variability of passive role frequency volatility. Table 5:Multivariate regression analysis with the patient The vast majority of the study patients
knew their diagnosis was cancer (91.3%). Also, the largest percentage (57.9%)
of them preferred to play a passive role in the decision-making procedures
regarding cancer treatment. Both awareness of diagnosis and active/shared
decision-making role were significantly associated with younger age and higher
educational level. Out of 229, 209 (91.3%) knew they
suffered from cancer. Awareness of cancer diagnosis was found to be
considerably associated with age, residence, educational level, and monthly
personal income of the study patients. In particular, the elderly, patients who
live in semi-rural and rural areas, patients with only compulsory education and
those with an individual income of less than 600 euros per month were found to
be unaware of cancer diagnosis in a higher rate. In a study on Greek cancer
patients regarding awareness of cancer diagnosis conducted the previous decade
found that 59% of cancer patients stated that they did not know their diagnosis
[25]. Awareness
of diagnosis was also significantly related to younger age and higher
educational level, but also to female gender. In another study on Greek
population in 2002, the percentage of patients who were unaware of cancer
diagnosis was 63%. In this study, cancer patients who were mainly aware of
their diagnosis were younger, high/secondary school or university graduates and
suffering from breast cancer [6]. The Greek culture widely supports the
ignorance of diagnosis in cancer patient, while the greater supporters of this
phenomenon are the members of patients’ families. In Greece, family ties are
particularly strong and family members share an intense feeling of offer and
solidarity. Patients rely heavily on their family when they have serious
problems and, above all, health problems, but relatives themselves usually
experience patient health issues as a family issue and are actively involved in
the process of dealing with the disease [31]. In the context of this protection, the
fact that the diagnosis of cancer causes anxiety and sadness to patients,
especially the elderly, who may feel helpless to cope with the disease’s
challenges, relatives try to protect them by intervening and concealing not
only the real diagnosis but even the type of the given treatment. This tactic, although
still used nowadays, has gradually been replaced by the necessity of revealing
the truth to cancer patients. A recent study in Turkey, where family ties are
equally strong, shows that diagnosis has been hidden in cancer patients at high
rates. The reasons why patients' relatives
conceal the diagnosis of cancer are to a great extent the anxiety and
depression it may cause to sufferers. Specifically, in 129 newly diagnosed
cancer patients, 29.5% had no knowledge of the diagnosis, while relatives claimed
that revealing the truth would cause them severe psychological problems [32]. The same year in a study in India, where
socio-cultural conditions and perceptions also seem to impede disclosure of
diseases such as cancer, the vast majority of the cancer patients were unaware
of their diagnosis. Specifically, only 29.9% of patients, most of them with
non-small cell lung cancer and advanced disease knew they had cancer [33]. The previous decade in a study carried
out in Norway, it was found that awareness of diagnosis of cancer patients was
not certain. Specifically, 20% of study patients claimed that they did not know
they had cancer. These patients were predominantly male, very young or elderly
and smokers [34]. In a recent study in Philadelphia, it was found that the
increased education level of cancer patients was significantly associated with
increased level of awareness of cancer staging [35]. The study concluded that
health professionals must recognize patients who require special attention due
to their age or education level and evaluate whether they understood what their
doctors explained to them regarding their disease and treatment. On the other hand, revealing cancer
diagnosis is an unpleasant process for healthcare professionals as well. Given
the assumption that the disclosure of bad news may cause anxiety
and sadness to patients their families, they choose to hide the diagnosis of
cancer and ask the medical and nursing staff to do the same in an attempt to
protect them [36,37]. Breaking bad news to cancer patients is causing a great
anxiety to healthcare professionals, as they often do not know how to
communicate the news with the patient, without causing sadness and unpleasant
reactions. In addition, as it has been reported in previous studies, healthcare
professionals have difficulty in using the appropriate language and
understandable terms to simply and effectively explain to patients the details
of their disease and treatment [38,39]. The disclosure of this truth has been a
difficult process even for the most experienced doctors and nurses [40].
However, Greek healthcare professionals tend to increasingly adopt
international models of disclosure to cancer patients, although this process
remains particularly inconvenient and stressful for them [41,42]. It is, therefore, concluded that
awareness of diagnosis of cancer patients depend on different factors, which
are associated with health care professional as well as cancer patients and
their families. As far as the patient's preferences in
decision making procedure are concerned, the results of the statistical
analysis showed that 36.2% of cancer patients want to co-decide with their
doctor on their treatment, choosing the shared decision-making role. Only 5.8%
of the patients preferred a more active role, while 57.9% preferred a more
passive role, with 24.6% of them preferring a fully passive role, where the
doctor takes all responsibility for the treatment decisions. Also, it was found
that older and lower-educated patients preferred, in a higher rate, a more
passive decision-making role. In line with the above, another study has been,
recently, conducted on breast cancer patients in Greece. The majority of
patients wished to have a passive role in the decision making process (71.1%),
with most patients (45.3%) wanting their doctor to take full responsibility for
cancer treatment decisions. The shared decision role was chosen by 24% of
patients [16]. In a study among cancer patients, in
Canada, the roles in the treatment decision making process patients preferred
were 26% active, 25% passive and 49% collaborative. Older patients, women and
Canadian patients than US patients were more likely to assume a passive role.
Moreover, in a study in Switzerland, the vast majority of cancer patients (79.1%)
agreed to the statement “one should stick to the physician advice even if one
is not fully convinced of his idea”. Older patients and less educated patients
were more likely to agree to this statement [29,43]. Arguably, older cancer patients have
grown up in an era characterized by the “doctor-centered” model, which may help
to explain their more passive role in the decision-making procedures. It was
then believed that a patient would seem as “good customer”, trusting whatever
the doctor suggested, without asking for more information or discuss treatment
options [12]. Also, older patients might have lost hope, be depressed or
overwhelmed by cancer-related symptoms and thus be unwilling to participate in
the decision-making process [4]. On the other hand, patients with higher
education level might have the ability to better access and understand medical
information, which may affect patients’ preferred role in the decision-making
procedure with the health care team. Knowledge is power and it is certainly
easier for a patient with a good educational background to understand the
doctor’s words, ask questions and make choices [44]. The rate at which Greek cancer patients
choose a passive role in the decision making process is the highest compared to
the corresponding percentage in both past and recent studies, internationally [45-56].
In a recent study in Spain, 21.2% of cancer patients receiving palliative care
for their disease preferred a passive role in treatment decision process; while
in the USA the percentage was still comparatively lower (13%) [57,58]. Many factors are likely related with the
choice of passive role from Greek cancer patients. The paternalistic model of
treatment decision-making, which is still largely prevalent in Greece, affects
the counseling process with the health care team. Patients, usually, play a
passive role in consultation and may have learned from past experiences that a
more active role will not be easily accepted by healthcare professionals. Also,
patients are likely to think that by choosing a more active role, they may seem
recalcitrant patients and therefore not receive the proper care. Finally, apart
from the paternalistic model in the doctor-patient relationship and the fear of
the quality of care provided, the choices of Greek patients are likely to be
influenced by their families, whose role is more intrusive in our country,
resulting many times, as already mentioned, in concealing information from
patients regarding diagnosis and the developments in their health status [16,41]. An additional factor that is not often
mentioned but can greatly influence the degree to which patients will be
involved in the decision making procedure is the enormous lack of time on
behalf of healthcare professionals in order to allow time to further promote
discussion and communication with the patients and their family members. In the
recent years, hospitals in Greece are clearly under-staffed suffering serious
shortages in both materials and building infrastructure, which causes serious
problems in coordination, organization of time, and communication ultimately
causing a reduction of the quality of holistic care provided to patients
[41,59]. Active involvement of cancer patients in
decision-making procedures regarding treatment requires a safe and calm
environment, as well as healthcare professionals with high communication
skills. The patients and their families should have adequate time to discuss
with the healthcare team, share their concerns and express their wishes in
order to make the appropriate decisions, with which they would feel
comfortable, confident and satisfied. In addition, healthcare professionals
should promote patients expression of possible changes in their decisions, as
well as, the wish for further or detailed information regarding disease and
treatment [60]. Therefore, the combination of
inappropriate communication environment and the occupational exhaustion of
doctors and nurses in Greek hospitals make it difficult for patients to
participate in therapeutic decision-making in a more active way [41]. This study concerns a rather underrated
issue in Greece and a difficult issue to discuss with Greek patients. In Greek
reality, almost the last two decades, the enormous lack of healthcare
professionals, nursing staff and doctors along with the remaining hesitation of
patients in getting the information they need for cancer diagnosis, derive them
from their right to actively participate in decision-making procedures [16,18,27].
That is the reason why there are very few studies on the matter in Greece
throughout the years. On the other hand, in Netherlands, researchers conducted
a study about the preferences of cancer patients between two main treatments
for early glottic
cancer, which indicates that patients, in other countries in Europe, not
only participate in decision making processes, nowadays, but also choose
between treatments, when given a choice [61]. Therefore, the conduction of this
study managed to provide health care professionals with the actual preferences
of Greek cancer patients regarding their participation in decision-making and
to emphases the need for better communication between health care professionals
and cancer patients. This study had some limitations. The
study sample consisted of patients suffering from various cancer types and the
disease duration ranged from recent to many years. This may have confused
patients about the therapeutic decisions they had taken, perhaps, several years
ago and which could have changed over time. In addition the study sample was
relatively small, which might affect the external validity of the study. Also,
the study sample gathered from a single general hospital in Athens, which not
only limited its number, but it might affected the results, since patients from
purely cancer hospitals might be more aware of diagnosis and more active in the
decision-making procedures. Perhaps, a multicenter study would have yielded
more representative results and allow for additional correlations. The results of the study showed that
Greek patients are more aware about cancer diagnosis, nowadays, but wish to
have a mainly passive and, to a lesser extent, a shared-decision role in the
decision-making procedures. This fact shows that the prevalent paternalistic
model of doctor-patient relationship in Greek reality may overshadow the
patients' actual needs and hinter the expression of their wishes or objections
to decisions regarding treatment. This study, also, supports the need for a
unique and personalized patient care, at a time that in the country where the
study conducted, thousands of desperate people from different cultures are
flocking every day and the migration issue is a front line issue. Therefore,
even if the study results seem to address to Greek cancer patients, the truth
is that they apply to any cancer patient, who needs honest and person-centered medical
and nursing care and they could be included to cultural and migration patterns
round the world. Thus, health professionals should approach each patient and
his/her needs uniquely, by providing the appropriate information and options
available for cancer treatment, while being continuously alerted for signs of
intense anxiety and patient dissatisfaction. Despoina G Alamanou, 2nd Internal Medicine Department, 417 NIMTS Hospital of Athens, Greece,Tel: +00306937509784, E-mail: despina_alamanou@hotmail.com Alamanou DG, Giakoumidakis K, Theodosiadis DG, Fotos NV, Patiraki E, et al. Awareness of diagnosis and decision-making preferences of greek cancer patients (2020) Pharmacovigil and Pharmacoepi 3: 5-12. Cancer,
Decision-making, Diagnosis, Oncology, Patients' participation, Patients'
preferences, Role preference.Awareness of Diagnosis and Decision-Making Preferences of Greek Cancer Patients
Abstract
Full-Text
Methods
Results





Discussion
Strengths
Limitations
Conclusions
References
*Corresponding author
Citation
Keywords